United States · FDA National Drug Code directory

glydo

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
25021-673_17e6ad03-b5bc-4930-8db5-e787ef954448
Product NDC
25021-673
Form
JELLY
Composition / generic term
lidocaine hydrochloride
Labeler
Sagent Pharmaceuticals
Marketing category
ANDA
Marketing start / end (source format)
20140915
Source listing expiry
20271231

Source-listed ingredients

  • LIDOCAINE HYDROCHLORIDE ANHYDROUS — 20 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 SYRINGE in 1 CARTON (25021-673-76) / 6 mL in 1 SYRINGE · 25021-673-76
  • 10 SYRINGE in 1 CARTON (25021-673-77) / 11 mL in 1 SYRINGE · 25021-673-77

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →